Error: Could not add to watchlist. X
+ Watchlist

AbbVie Biotherapeutics Inc

FACT:US
Acquired
FACT:US was acquired by ABBV:US
USD
Volume
0
Before it's here, it's on the Bloomberg Terminal.
Learn More
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-5.11
Market Cap (USD)
-
Shares Outstanding (m)
25.093
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
AbbVie Biotherapeutics Inc. operates as a biopharmaceutical company. The Company develops drugs for the treatment of multiple sclerosis, ovarian and lung cancers, multiple myeloma, tumors, and immune system diseases. AbbVie Biotherapeutics serves clients worldwide.
Address
1 North Waukegan Road
North Chicago, IL 60064-6163
United States
Phone
1-800-255-5162
Show More